Brinzolamide Intermediate (CAS 160982-11-6) | Premium-Grade API Synthesis Material
Google Search Keywords: Brinzolamide Intermediate, CAS 160982-11-6, API Synthesis Intermediate, Carbonic Anhydrase Inhibitor Precursor, Pharmaceutical Building Block
🔬 Product Overview
Brinzolamide Intermediate (CAS 160982-11-6) is a vital chemical precursor in the synthesis of Brinzolamide, a widely used carbonic anhydrase inhibitor for treating glaucoma and ocular hypertension. This intermediate ensures high-efficiency, scalable production of Brinzolamide API while maintaining strict quality benchmarks.
Primary Function: Enables precise and cost-effective API synthesis.
Applications: Pharmaceutical manufacturing, generic drug development, process chemistry.
✅ Key Advantages
⭐ Ultra-High Purity
⚙️ Process Optimization
🌡️ Robust Stability
📋 Applications
API Production: Core component in Brinzolamide API batch manufacturing.
Generic Drug Formulations: Supports affordable ophthalmic drug development.
Chemical Research: Used in catalyst studies and reaction mechanism optimization.
🏅 Quality Certifications
Rigorously analyzed via HPLC, GC, NMR, and Mass Spectrometry (aligned with ICH Q11 and USP/EP guidelines).
Full traceability with batch-specific Certificates of Analysis (CoA).
🌐 Market Trends
The global API intermediates market is projected to expand at 6.5% CAGR (2023-2030), driven by rising glaucoma prevalence and demand for cost-efficient generics. Brinzolamide intermediates are critical to meeting supply chain needs in ophthalmic drug manufacturing.
🔍 Why Choose Us?
Bulk & Custom Orders: Flexible quantities and tailored synthesis protocols.
Global Logistics: Fast shipping with temperature-controlled options.
Technical Expertise: End-to-end support for API development and scale-up.
China
